Price
No data yet.
Social Signal Score
Revenue
$3.94MCompany Profile
- CEO
- Henry Dubina
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 5
- Beta
- 1.33
- Country
- CA
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -3.46
Financials
Revenue
$3.94M+561.7%Net Income
$8.78MEBITDA
$-5.66MFree Cash Flow
—EPS (diluted)
$0.11Shares Outstanding (diluted)
80.80M+69.1%Operating Expenses
$9.60MCash & Debt
—Return of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $9.16M | $4.53M | $0.06 |
| 2025 | $4.78M | $-1.56M | $-0.03 |
| 2023 | $2.82M | $-718.1K | $-0.01 |
| 2022 | $595.4K | $-5.75M | $-0.12 |
| 2021 | $0.00 | $-4.03M | $-0.08 |
| 2020 | $0.00 | $-253.0K | $-0.01 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $0.08
- Implied price
- $0.82
- Return from $0.18
- 35.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.41 — today's price is already 55.4% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| -2.0% | 10.7% | 17.3% | 22.6% | 27.2% | 31.2% |
| 3.0% | 16.4% | 23.3% | 28.9% | 33.7% | 37.9% |
| 8.0% | 22.0% | 29.3% | 35.2% | 40.2% | 44.6% |
| 13.0% | 27.7% | 35.2% | 41.4% | 46.7% | 51.3% |
| 18.0% | 33.3% | 41.2% | 47.7% | 53.2% | 58.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (7)
- Newsnewsfilecorp.com·24d ago·Neutral
…ssociation, representing approximately 300 member companies Seoul, South Korea--(Newsfile Corp. - October 29, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories ("SDL"), yesterday joined senior Canadian government and diplomatic leaders at the Korean Pharmaceutical and Biopharmaceutical Manufacturer's Association ("KPBMA") in Seoul to visit the facility's Self-Dr…
View source ↗ - Newsnewsfilecorp.com·31d ago·Neutral
…industries to meet investors October 27, 28 and 29 Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories ("SDL"), enabling technologies, and services for the global pharmaceutical and high-value chemical industries, today announced that members of its leadership team will attend the Planet MicroCap Toronto I…
View source ↗ - Newsnewsfilecorp.com·34d ago·Neutral
…ndscape for AI-driven decision-making in biopharma Vancouver, British Columbia--(Newsfile Corp. - October 19, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories ("SDL"), enabling technologies, and services for the global pharmaceutical and high-value chemical industries, today announced that it has been chosen to join the Canadian business delegation to BIOPLUS-I…
View source ↗ - Newsnewsfilecorp.com·47d ago·Neutral
…utical industries to meet investors October 7 and 8 Vancouver, British Columbia--(Newsfile Corp. - October 6, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories ("SDLs"), and enabling technologies and services for the global pharmaceutical and high-value chemical industries, today announced that members of its leadership team will be in Toronto on October 7 and 8, 2026, inc…
View source ↗ - Newsnewsfilecorp.com·48d ago·Neutral
…, contract services, and DirectInject-LC(TM) sales Vancouver, British Columbia--(Newsfile Corp. - October 5, 2026) - Telescope Innovations Corp. (CSE: TELI), (OTCQB: TELIF), (FSE: J4U), ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories ("SDL"), enabling technologies, and services for the global pharmaceutical and chemical industries, today reported 60% growth in gross revenue for fiscal 2026, with revenue reaching C$9.3 million, compa…
View source ↗ - Newsnewsfilecorp.com·60d ago·Neutral
…le Cloud Laboratories Kickoff in Washington, DC Vancouver, British Columbia--(Newsfile Corp. - September 23, 2026) - Telescope Innovations Corp. (CSE: TELI), (OTCQB: TELIF), (FSE: J4U), ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories, and enabling technologies and services for the global pharmaceutical and high-value chemical industries, announces that Chief Technology Officer Prof. Jason Hein has been requested to participate in th…
View source ↗ - Newsnewsfilecorp.com·95d ago·Neutral
…ment of Dr. E. Neil Lewis to the Board of Directors Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company" or "Telescope"), a leading developer of Physical AI systems, including Self-Driving Laboratories, and enabling technologies and services for the global pharmaceutical and high-value chemical industries, is pleased to announce the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), …
View source ↗
Congress trades
No disclosed congressional trades in TELIF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
